B Bizzini

4.4k total citations
175 papers, 3.5k citations indexed

About

B Bizzini is a scholar working on Immunology, Molecular Biology and Virology. According to data from OpenAlex, B Bizzini has authored 175 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Immunology, 42 papers in Molecular Biology and 36 papers in Virology. Recurrent topics in B Bizzini's work include Botulinum Toxin and Related Neurological Disorders (34 papers), HIV Research and Treatment (33 papers) and Diphtheria, Corynebacterium, and Tetanus (28 papers). B Bizzini is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (34 papers), HIV Research and Treatment (33 papers) and Diphtheria, Corynebacterium, and Tetanus (28 papers). B Bizzini collaborates with scholars based in France, Belgium and United States. B Bizzini's co-authors include Daniel Zagury, Robert C. Gallo, E. H. Relyveld, Shlomo Ben‐Efraim, M Raynaud, Arsène Burny, Erik B. Lindblad, Gupta Rk, Hélène Le Buanec and Chander Kanta Gupta and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Virology and Biochemical Journal.

In The Last Decade

B Bizzini

165 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B Bizzini France 32 1.7k 1.2k 894 513 483 175 3.5k
Kenneth E. Ugen United States 38 2.6k 1.6× 2.5k 2.1× 1.5k 1.7× 929 1.8× 172 0.4× 121 6.8k
Michael J. Hayman United States 44 1.4k 0.8× 3.9k 3.4× 254 0.3× 749 1.5× 155 0.3× 152 6.8k
Berish Y. Rubin United States 36 3.4k 2.0× 1.7k 1.5× 482 0.5× 1.6k 3.1× 96 0.2× 83 7.0k
Kohji Moriishi Japan 41 949 0.6× 2.4k 2.1× 342 0.4× 1.8k 3.5× 431 0.9× 145 5.8k
Hans S.L.M. Nottet Netherlands 31 2.1k 1.3× 1.1k 1.0× 3.1k 3.5× 753 1.5× 84 0.2× 52 5.5k
Hubert Reggio France 30 746 0.4× 2.2k 1.9× 129 0.1× 571 1.1× 132 0.3× 50 3.9k
Michael D. Power United States 11 485 0.3× 1.4k 1.2× 1.1k 1.3× 401 0.8× 165 0.3× 15 3.0k
Dirk Schlüter Germany 49 1.7k 1.0× 1.5k 1.3× 268 0.3× 1.9k 3.7× 264 0.5× 145 5.9k
R M Zinkernagel Switzerland 24 2.1k 1.2× 568 0.5× 297 0.3× 621 1.2× 60 0.1× 37 3.3k
John J. Callanan Ireland 34 731 0.4× 817 0.7× 395 0.4× 541 1.1× 70 0.1× 112 4.0k

Countries citing papers authored by B Bizzini

Since Specialization
Citations

This map shows the geographic impact of B Bizzini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Bizzini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Bizzini more than expected).

Fields of papers citing papers by B Bizzini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Bizzini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Bizzini. The network helps show where B Bizzini may publish in the future.

Co-authorship network of co-authors of B Bizzini

This figure shows the co-authorship network connecting the top 25 collaborators of B Bizzini. A scholar is included among the top collaborators of B Bizzini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Bizzini. B Bizzini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buanec, Hélène Le, Isabelle Couillin, Silvia Schnyder‐Candrian, et al.. (2007). Control of allergic reactions in mice by an active anti-murine IL-4 immunization. Vaccine. 25(41). 7206–7216. 20 indexed citations
2.
Zagury, Daniel, Hélène Le Buanec, B Bizzini, et al.. (2003). Active versus passive anti-cytokine antibody therapy against cytokine-associated chronic diseases. Cytokine & Growth Factor Reviews. 14(2). 123–137. 37 indexed citations
3.
Buanec, Hélène Le, A Lachgar, Jean‐François Zagury, et al.. (1999). Induction of cellular immunosuppression by the human papillomavirus type 16 E7 oncogenic protein. Biomedicine & Pharmacotherapy. 53(7). 323–328. 19 indexed citations
4.
Gringeri, A., Elena Santagostino, Hélène Le Buanec, et al.. (1999). Tat Toxoid as a Component of a Preventive Vaccine in Seronegative Subjects. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 20(4). 371–375. 28 indexed citations
5.
Gringeri, A., Massimo Musicco, P. Hermans, et al.. (1999). Active Anti-Interferon-α Immunization: A European-Israeli, Randomized, Double-Blind, Placebo-Controlled Clinical Trial in 242 HIV-1-Infected Patients (the EURIS Study). Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 20(4). 358–370. 54 indexed citations
6.
Bizzini, B, et al.. (1999). IFNα kinoid vaccine in conjunction with tritherapy, a weapon to combat immunopathogenesis in AIDS. Biomedicine & Pharmacotherapy. 53(2). 87–89. 8 indexed citations
7.
Buanec, Hélène Le, A Lachgar, B Bizzini, et al.. (1998). A prophylactic and therapeutic AIDS vaccine containing as a component the innocuous Tat Toxoid. Biomedicine & Pharmacotherapy. 52(10). 431–435. 12 indexed citations
8.
Bizzini, B, et al.. (1998). Binding of HIV-1 to RBCs involves the Duffy Antigen Receptors for Chemokines (DARC). Biomedicine & Pharmacotherapy. 52(10). 436–439. 46 indexed citations
9.
Cantalloube, Hubert, Gilles Labesse, Jacques Chomilier, et al.. (1995). Automat and BLAST: comparison of two protein sequence similarity search programs. Computer applications in the biosciences. 11(3). 261–272. 5 indexed citations
10.
Rk, Gupta, E. H. Relyveld, Erik B. Lindblad, et al.. (1993). Adjuvants — a balance between toxicity and adjuvanticity. Vaccine. 11(3). 293–306. 436 indexed citations
12.
Mathieu, Danièle, et al.. (1991). Pneumococcal vaccination of elderly individuals. Vaccine. 9(8). 542–544. 14 indexed citations
13.
Zummo, Sebastiana, et al.. (1990). A dot‐elisa for the detection of igg antibodies to mumps and varicella viruses. Journal of Clinical Laboratory Analysis. 4(3). 165–169. 2 indexed citations
15.
Veronesi, R, et al.. (1983). Tratamento especifico do tetano com uma fracao-f(ab')-da imunoglobulina antitetanica injetada por via raquidiana. 38(4). 147–149. 2 indexed citations
16.
Relyveld, E. H., E Hénocq, & B Bizzini. (1979). Studies on untoward reactions to diphtheria and tetanus toxoids.. PubMed. 43. 33–7. 14 indexed citations
17.
Jacques, Line, et al.. (1978). [Variations in the phagocytic potency of circulating leukocytes from rats which received a thermal injury. Effects of an immunostimulation with Corynebacterium granulosum (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 26(8). 495–502. 3 indexed citations
18.
Bizzini, B, et al.. (1976). Effet antagoniste d'une fraction isolée de Corynebacterium granulosum envers le pouvoir immunosuppresseur de la cyclophosphamide chez la souris. Comptes rendus hebdomadaires des séances de l Académie des sciences. 283(6). 4 indexed citations
19.
Bizzini, B & M Raynaud. (1975). Studies on the antigenic structure of tetanus toxin.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 126(2). 159–76. 4 indexed citations
20.
Raynaud, M, et al.. (1954). Growth and Toxin Formation.. Ann. Inst. Pasteur. 87(1). 599–616. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026